Nrlın:Ocov, M:28Q, Bact, Cmpny, Covıd, Cprod, Dıp, Epmıcs, Gen, Genhlt, Hea, Heca, Humdıs, Infdıs, Intag, Medreg, Medst, Oms, Phag08, Phar, Phar08, Phar1, Phmr, Pol, Pubhea, Regs, Un1, Wash, Sasıa, Amers, In, Namer, Asxpac, Emrg, Asıa, Topcmb, Topnws, Nrlpa:Ohlt, Nrlpa:Oıp, Legal, Reuters-Legal

Nrlın:Ocov, M:28Q

Merck signs pact to broaden generic manufacturing of COVID-19 pill

Merck signs pact to broaden generic manufacturing of COVID-19 pill

10/27/2021 5:01:00 PM

Merck signs pact to broaden generic manufacturing of COVID -19 pill

Merck & Co has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that will allow more companies to manufacture generic versions of its experimental oral antiviral COVID -19 treatment, the U.S. drugmaker and the organization announced on Wednesday.

Ahmed Aboulenein2 minute readThe Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidWASHINGTON, Oct 27 (Reuters) - Merck & Co(MRK.N)has signed a licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) that will allow more companies to manufacture generic versions of its experimental oral antiviral COVID-19 treatment, the U.S. drugmaker and the organization announced on Wednesday.

Where to buy USA-made Christmas gifts this year Ohio Army National Guard Spc. Michaela Nelson has been missing for a month Thailand bans entry of people travelling from eight African countries

Merck said the royalty-free license would apply to 105 low- and middle-income countries. It allows manufacturers selected by MPP to make generic versions of molnupiravir, the antiviral pill Merck has developed with Ridgeback Biotherapeutics.The U.S. Food and Drug Administration is considering emergency use authorization of the medicine, which was shown in

a clinical trialto halve the risk of serious disease and death when given early for COVID-19."This is the first transparent, public health-driven voluntary license for a COVID-19 medical technology," Merck and MPP said in a joint statement.Companies will be able to apply for a sub-license from MPP and the license, which also includes technology transfer, will remain royalty-free so long as the World Health Organization classifies the pandemic as a "Public Health Emergency of International Concern," the statement said. headtopics.com

Medical charity Medecins Sans Frontieres (MSF), however, expressed disappointment with the limitations of the license as its territory excludes nearly half of the world's population and upper-middle-income countries with robust manufacturing capacities, such as Brazil and China.

MSF, also known as Doctors Without Borders, said in a statement the agreement contains a provision undermining the right of generic companies who sign the license to challenge patents to facilitate generic-drug production. Read more: Reuters Top News »

‘Spider-Man: No Way Home’ Trailer Reveals Villainous Multiverse as Tom Holland Teases ‘That Is the Tip of the Iceberg’

The second trailer for “Spider-Man: No Way Home” premiered on Tuesday, a little over a month ahead of the Sony Pictures and Marvel Studios co-production’s exclusive theatrical rel…

Giving it away..no wonder NEW DELHI (Reuters) - Merck & Co's experimental antiviral drug molnupiravir has not shown 'significant efficacy' against moderate COVID-19, Drug Controller General of India said 'There is no significant efficacy against moderate COVID and mild cases,' Biz Merck donated to Africa a drug for 'river blindness,' that it could not sell to developed countries, but this is the 1st donation of a drug that would sell well.. - Merck signs pact to broaden generic manufacturing of COVID-19 pill

Covid-19: Record case rates in Wales and long Covid study begins in ScotlandFive things you need to know about the coronavirus pandemic this Tuesday evening.

U.S. drug company Merck to share license for experimental covid-19 treatment with non-profitU.S. pharmaceutical giant Merck has agreed to share its license with a non-profit so that its experimental covid-19 drug, molnupiravir, can be manufactured widely around the world in a deal that would expand access in more than 100 countries

Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-OldsModerna said it would submit the results from an interim study to health regulators in the U.S., Europe and elsewhere in seeking authorization for 6- to 11-year-olds. Also note the use of “induced the desired immune response” rather than “protected them from COVID”. If they’re like Pfizer, that’s because not enough kids got sick (in either group) to test that. 🤣🤣🤣

Moderna Says Its Low-Dose COVID-19 Vaccine Works For Kids 6 To 11Children who received the vaccine developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said. Have they submitted the safety data?

Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults. My Kids will never get the vaccine. That is freakin ass LIE! All vaccines are deadly poisin. Vaccines are killing people and newborn babies. So if you wanna die, and/or your newborn die DO NOT TAKE THE VACCINES [they are killing people. That is 100% TRUE! Child abuse.

EU regulator starts real-time review of Merck's COVID-19 pillU.S. drugmaker Merck & Co Inc said on Monday the European Union's drug regulator has initiated a real-time review of its experimental COVID -19 antiviral drug for adults.